Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,918 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation.
Wada H, Kanda J, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Tanihara A, Nishida J, Kanda Y. Wada H, et al. Among authors: sakamoto k. Hematology. 2018 Jun;23(5):271-276. doi: 10.1080/10245332.2017.1396026. Epub 2017 Oct 31. Hematology. 2018. PMID: 29086660 Free article.
Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation.
Ishida Y, Terasako K, Oshima K, Sakamoto K, Ashizawa M, Sato M, Kikuchi M, Kimura S, Nakasone H, Okuda S, Kako S, Yamazaki R, Nishida J, Kanda Y. Ishida Y, et al. Among authors: sakamoto k. Int J Hematol. 2010 Oct;92(3):542-6. doi: 10.1007/s12185-010-0678-6. Epub 2010 Sep 8. Int J Hematol. 2010. PMID: 20824399
Association between serum high-molecular-weight adiponectin level and the severity of chronic graft-versus-host disease in allogeneic stem cell transplantation recipients.
Nakasone H, Binh PN, Yamazaki R, Tanaka Y, Sakamoto K, Ashizawa M, Sato M, Terasako K, Kimura S, Kikuchi M, Kako S, Okuda S, Oshima K, Tanihara A, Nishida J, Abe Y, Kanda Y. Nakasone H, et al. Among authors: sakamoto k. Blood. 2011 Mar 24;117(12):3469-72. doi: 10.1182/blood-2010-10-316109. Epub 2011 Jan 21. Blood. 2011. PMID: 21258011 Free article.
Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation.
Yamazaki R, Nakasone H, Tanaka Y, Sato M, Terasako K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Yamazaki R, et al. Among authors: sakamoto k. Biol Blood Marrow Transplant. 2013 Jul;19(7):1013-20. doi: 10.1016/j.bbmt.2013.04.007. Epub 2013 Apr 10. Biol Blood Marrow Transplant. 2013. PMID: 23583826 Free article.
Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
Ashizawa M, Kimura S, Wada H, Sakamoto K, Sato M, Terasako K, Kikuchi M, Nakasone H, Okuda S, Kako S, Yamazaki R, Oshima K, Matsuura K, Ohmori T, Madoiwa S, Nishida J, Mimuro J, Tabei K, Sakata Y, Kanda Y. Ashizawa M, et al. Among authors: sakamoto k. Hematology. 2013 Sep;18(5):300-4. doi: 10.1179/1607845412Y.0000000072. Epub 2013 May 15. Hematology. 2013. PMID: 23683688 Free article.
Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation.
Kanda Y, Wada H, Yamasaki R, Kawamura K, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Tsunoda H, Omori Y, Nakazawa M, Tanaka O. Kanda Y, et al. Among authors: sakamoto k. Ann Hematol. 2014 Feb;93(2):287-92. doi: 10.1007/s00277-013-1852-8. Epub 2013 Jul 28. Ann Hematol. 2014. PMID: 23892927 Clinical Trial.
The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL.
Machishima T, Kako S, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Yamazaki R, Nishida J, Kanda Y. Machishima T, et al. Among authors: sakamoto k. Clin Transplant. 2013 Sep-Oct;27(5):749-56. doi: 10.1111/ctr.12213. Epub 2013 Aug 20. Clin Transplant. 2013. PMID: 24033855
Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.
Sakamoto K, Nakasone H, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Sato M, Terasako-Saito K, Machishima T, Kimura S, Kikuchi M, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y. Sakamoto K, et al. PLoS One. 2013 Sep 5;8(9):e73754. doi: 10.1371/journal.pone.0073754. eCollection 2013. PLoS One. 2013. PMID: 24040054 Free PMC article.
Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y. Kawamura K, et al. Among authors: sakamoto k. Int J Infect Dis. 2014 Feb;19:26-32. doi: 10.1016/j.ijid.2013.09.020. Epub 2013 Nov 6. Int J Infect Dis. 2014. PMID: 24211377 Free article.
A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia.
Ashizawa M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y. Ashizawa M, et al. Among authors: sakamoto k. Int J Hematol. 2014 Mar;99(3):311-7. doi: 10.1007/s12185-014-1501-6. Epub 2014 Feb 1. Int J Hematol. 2014. PMID: 24488782
4,918 results